Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

Completed · Not applicable

Conditions studied: HIV Infections

In brief

To determine the efficacy of an improved rapid diagnostic test using venous whole blood and fingerstick whole blood. The clinical performance of Reveal G4 Rapid HIV-1 Antibody Test will be determined by comparing the results with patient infected status for HIV-1 (human immunodeficiency virus type 1). The study will consist of a single one-hour visit, at which time blood samples will be collected and tested with the investigational device (Reveal G4) and FDA approved comparator assays for detection of HIV-1 antibodies.

Key facts

Study ID
NCT02190578
Run by
MedMira Laboratories Inc.
People needed
1649
Starts
2014-07-01
Expected to finish
2015-03-01
Last updated by the study team
2015-04-24

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.